80.37
-0.96 (-1.18%)
At close: Jun 1, 2021
80.37
0 (0%)
After Hours: 6/1/2021, 8:24:59 PM
CMD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. CMD may be in some trouble as it scores bad on both profitability and health. CMD is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- CMD had positive earnings in the past year.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.56% | ||
| ROE | 6.37% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.54% | ||
| PM (TTM) | 4.57% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 2.98 indicates that CMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
- CMD has a Debt/Equity ratio of 0.90. This is a neutral value indicating CMD is somewhat dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.98 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 2.58 indicates that CMD has no problem at all paying its short term obligations.
- A Quick Ratio of 1.84 indicates that CMD should not have too much problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
- The earnings per share for CMD have decreased strongly by -29.96% in the last year.
- CMD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.92% yearly.
- CMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.37%.
- Measured over the past years, CMD shows a quite strong growth in Revenue. The Revenue has been growing by 12.45% on average per year.
EPS 1Y (TTM)-29.96%
EPS 3Y-4.57%
EPS 5Y25.92%
EPS Q2Q%27.03%
Revenue 1Y (TTM)11.37%
Revenue growth 3Y9.68%
Revenue growth 5Y12.45%
Sales Q2Q%32.51%
3.2 Future
- The Earnings Per Share is expected to grow by 21.07% on average over the next years. This is a very strong growth
- Based on estimates for the next years, CMD will show a quite strong growth in Revenue. The Revenue will grow by 8.80% on average per year.
EPS Next Y82.92%
EPS Next 2Y37.5%
EPS Next 3Y29.83%
EPS Next 5Y21.07%
Revenue Next Year17.48%
Revenue Next 2Y11.96%
Revenue Next 3Y10.48%
Revenue Next 5Y8.8%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 48.42 indicates a quite expensive valuation of CMD.
- The average S&P500 Price/Earnings ratio is at 28.30. CMD is valued rather expensively when compared to this.
- Based on the Price/Forward Earnings ratio of 25.61, the valuation of CMD can be described as expensive.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.57, CMD is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.42 | ||
| Fwd PE | 25.61 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 19.45 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as CMD's earnings are expected to grow with 29.83% in the coming years.
PEG (NY)0.58
PEG (5Y)1.87
EPS Next 2Y37.5%
EPS Next 3Y29.83%
5. Dividend
5.1 Amount
- CMD has a yearly dividend return of 0.13%, which is pretty low.
- With a Dividend Yield of 0.13, CMD pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.13% |
5.2 History
- The dividend of CMD is nicely growing with an annual growth rate of 25.79%!
- CMD has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)25.79%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- The dividend of CMD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y37.5%
EPS Next 3Y29.83%
Cantel Medical / CMD FAQ
What is the fundamental rating for CMD stock?
ChartMill assigns a fundamental rating of 5 / 10 to CMD.
Can you provide the valuation status for Cantel Medical?
ChartMill assigns a valuation rating of 4 / 10 to Cantel Medical (CMD). This can be considered as Fairly Valued.
How profitable is Cantel Medical (CMD) stock?
Cantel Medical (CMD) has a profitability rating of 6 / 10.
What is the valuation of Cantel Medical based on its PE and PB ratios?
The Price/Earnings (PE) ratio for Cantel Medical (CMD) is 48.42 and the Price/Book (PB) ratio is 4.38.
How financially healthy is Cantel Medical?
The financial health rating of Cantel Medical (CMD) is 4 / 10.